US 11479595
Methods for modulating an immune response
granted A61KA61K2039/505A61K38/1774
Quick answer
US patent 11479595 (Methods for modulating an immune response) held by Cue Biopharma, Inc. expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cue Biopharma, Inc.
- Grant date
- Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K38/1774, A61K38/2013, A61K39/3955